Dermatology Treatment Devices Market Size, Trends and Growth Analysis by 2027

The global market for dermatology treatment devices is projected to grow significantly, reaching approximately US$ 8,800.07 million by 2027, up from US$ 5,320.73 million in 2019. This growth represents a compound annual growth rate (CAGR) of 6.7% from 2020 to 2027.

Several factors contribute to this upward trend, including the increasing incidence of skin disorders and advancements in technology related to dermatological devices. However, the potential for adverse side effects associated with these devices poses a challenge to market expansion.

Dermatology encompasses the diagnosis, prevention, and treatment of various conditions affecting the skin, hair, and nails, including issues like pigmentation disorders, acne, wrinkles, and psoriasis. The devices utilized in dermatology not only treat existing conditions but also help in the prevention of certain skin ailments. Key devices in this field include lasers, light therapy apparatus, cryotherapy tools, microdermabrasion machines, energy-based therapy devices, and microneedling instruments.

Ongoing research and development efforts are crucial for enhancing the understanding of skin-related medical issues. Companies are heavily investing in the creation of innovative medical devices to ensure a favorable return on investment (ROI). Furthermore, regulatory approvals from authorities enhance the trustworthiness and reliability of these modern products. For example, in January 2020, 3Derm Systems, Inc., a pioneer in skin imaging and diagnostics, received two breakthrough device designations from the U.S. Food and Drug Administration (FDA) for its product 3DermSpot, which employs artificial intelligence for the autonomous detection of melanoma, basal cell carcinoma, and squamous cell carcinoma.

Lasers have become integral to many dermatological treatment devices, with leading manufacturers launching innovative products in recent years. For instance, in September 2016, Alma Lasers unveiled Alma LipoLife 3G, a liposuction device that promises optimal safety and proven clinical outcomes, incorporating multiple stages of liposuction, fat grafting, and skin tightening. Additionally, in April 2019, Lumenis, a company specializing in energy-based medical devices, introduced Legand Pro+, a versatile platform for aesthetic and surgical applications, powered by four clinically validated technologies.

The accessibility of the internet and the proliferation of beauty blogs have significantly enhanced the reach of innovative products to target audiences. In April 2019, Alma Lasers launched BeautiFill, the first laser platform capable of generating high-quality autologous fat for facial and body contouring procedures. Similarly, in July 2018, Lumenis presented NuEra Tight at the Aesthetic Show, a high-power, temperature-controlled RF treatment for cellulite and skin laxity, designed for both deep and superficial heating. The increasing number of such product launches is propelling the growth of the dermatology treatment devices market.

In terms of product segmentation, the dermatology treatment devices market is categorized into lasers, light therapy devices, energy-based therapy devices, microdermabrasion devices, microneedling, and cryotherapy devices. In 2019, the lasers segment held the largest market share and is expected to maintain its dominance in the coming years. This is attributed to the growing acceptance of laser treatments for aesthetic and dermatological concerns, the rising popularity of laser-based procedures, and the reliability of treatment outcomes. Moreover, the introduction of cost-effective lasers for home use presents new growth opportunities for companies in the dermatology treatment devices sector.

The COVID-19 pandemic, which was first identified in December 2019 in Wuhan, China, has had widespread repercussions across various markets globally. The demand for dermatology treatment devices has diminished during this crisis, as the focus has shifted towards managing and preventing COVID-19. The ongoing pandemic continues to disrupt global supply chains, consumer markets, and economies, adversely affecting the growth of the dermatology treatment devices market.

Key organizations such as the Centers for Disease Control and Prevention (CDC), World Health Organization (WHO), European Union (EU), Organization for Economic Co-operation and Development, National Cancer Institute, American Academy of Dermatology Association, Central Intelligence Agency (CIA), and National Health Service (NHS) are among the primary secondary sources referenced in the preparation of this report.